Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
106.6 USD | -3.23% | -2.69% | +70.11% |
30/05 | Transcript : Natera, Inc. Presents at 2024 Leerink Partners Healthcare Crossroads Conference, May-30-2024 10:40 AM | |
23/05 | U.S. FDA advisers back approval for Guardant's cancer test | RE |
Sales 2024 * | 1.43B 119B | Sales 2025 * | 1.68B 140B | Capitalization | 13.08B 1,091B |
---|---|---|---|---|---|
Net income 2024 * | -304M -25.36B | Net income 2025 * | -144M -12.01B | EV / Sales 2024 * | 8.8 x |
Net cash position 2024 * | 476M 39.7B | Net cash position 2025 * | 522M 43.54B | EV / Sales 2025 * | 7.49 x |
P/E ratio 2024 * |
-42.5
x | P/E ratio 2025 * |
-91.4
x | Employees | 3,288 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.8% |
Latest transcript on Natera, Inc.
1 day | -3.23% | ||
1 week | -2.69% | ||
Current month | +0.03% | ||
1 month | +13.70% | ||
3 months | +19.18% | ||
6 months | +82.28% | ||
Current year | +70.11% |
Managers | Title | Age | Since |
---|---|---|---|
Stephen Chapman
CEO | Chief Executive Officer | 45 | 01/10/01 |
Jonathan Sheena
FOU | Founder | 51 | 01/03/01 |
Founder | 51 | 01/03/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
James Healy
BRD | Director/Board Member | 59 | 01/14/01 |
Roelof Botha
BRD | Director/Board Member | 50 | 01/07/01 |
Herm Rosenman
BRD | Director/Board Member | 76 | 01/14/01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.12% | 14 M€ | -5.07% | ||
1.06% | 2 M€ | -.--% | ||
0.40% | 0 M€ | 0.00% | - | |
0.38% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
31/24/31 | 106.5 | -3.26% | 1,297,876 |
30/24/30 | 110.1 | +0.27% | 694,022 |
29/24/29 | 109.8 | +0.23% | 881,547 |
28/24/28 | 109.6 | +0.05% | 1,003,354 |
Delayed Quote Nasdaq, May 01, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+70.11% | 13.08B | |
+25.52% | 88.99B | |
-24.52% | 74.82B | |
+0.49% | 25.03B | |
+4.31% | 17.88B | |
-14.25% | 16.43B | |
+2.97% | 15.77B | |
+79.20% | 13.21B | |
+40.44% | 12.9B | |
+24.51% | 12.7B |
- Stock Market
- Equities
- NTRA Stock